SP

Spok Holdings, Inc.

SPOKHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$139.7M
+1.5% YoY
Net Income
$15.9M
+6.1% YoY
EBITDA
$23.6M
-2.6% YoY
Free Cash Flow
$19.8M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 15 MACD Positive CrossoverHistogram +0.0113, positive momentum
Jul 14 MACD Positive CrossoverHistogram +0.0061, positive momentum
About Spok Holdings, Inc.

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. At a $222.7M market cap, Spok Holdings, Inc. ranks as a micro-cap company within healthcare. Its products and services enhance workflows for clinicians and support administrative compliance.

Where SPOK stands vs its 150-day and 200-day moving averages

As of the July 15, 2026 close, SPOK finished 8.20% below its 150-day moving average ($11.46) and 12.48% below its 200-day moving average ($12.02). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is SPOK overbought or oversold?

At the July 15, 2026 close, SPOK's RSI(14) was 44.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$222.7M
P/E (TTM)18.07
Fwd P/E12.69
EPS$0.59
Beta0.45
52W Change-39.3%
Dividend Yield11.74%
ROE8.7%
Analysis

The balance sheet looks solid with $17.1M in cash comfortably exceeding the $6.2M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $19.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 8.7%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $134.5M (2022) to $139.7M (2025).

The relatively low beta of 0.45 suggests SPOK is a less volatile holding compared to the broader index. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SPOK.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
SPOK: Spok Holdings, Inc. Technical Analysis (200-Day MA, RSI, MACD) | Scanance